Biography
Dr. Marjorie Dixon, MD, FRCSC, FACOG, REI, founded Anova Fertility & Reproductive Health (and co-founded First Steps Fertility in 2008-2016) after many years in practice in order to execute her vision of reproductive medicine where evidence-based medical care could be balanced with compassion for all patients who require assistance to create their families. Dr. Dixon is a graduate of the McGill University’s School of Medicine. Her initial postgraduate training was at the University of Toronto, in Obstetrics and Gynecology. Her passion for reproductive medicine continued during her postgraduate training with a 3-year subspecialty, American Board of Obstetrics and Gynecology accredited fellowship in Reproductive Endocrinology and Infertility at the University of Vermont. Dr. Dixon is an active member of the Department of Obstetrics and Gynecology at Sunnybrook Health Sciences Center and holds the position of Assistant Professor at the University of Toronto, where she actively participates in medical student and resident education. She continues to be an invited speaker at both national and international conferences in her field of Reproductive Endocrinology and Infertility. Of note, she was appointed to the province’s expert panel on Infertility and Adoption which submitted its report entitled “Raising Expectations†in 2009. The goal of the panel was to advise the Ontario government on how to improve access to fertility treatments and monitoring, as well as how to improve Ontario’s adoption system. Dr. Dixon has also been intimately involved in providing more recent advice on IVF funding for the Government of Ontario’s New Fertility Program in 2015. All in all, she feels that it is primordial to ensure the safe and effective delivery of Ontario’s constituents’ fertility healthcare. As a recognized expert in her field, Dr. Dixon is often asked to comment on newsworthy topics related to women’s health in the media. She appears monthly on Cityline as a part of their trusted group of experts often speaking to her responsibility and champion of women’s health and reproductive well-being. Click on this link to watch Dr. Marjorie Dixon’s segments on important women’s health topics: Cityline’s Health & Family segment (runs the second or third Wednesday of every month). In April 2015, Dr. Dixon & her staff were happy to announce the arrival of a healthy baby boy named Zain. He has the distinction of being the first baby born in the world using Augment treatment. The Augment treatment is administered as a part of an IVF cycle, in which the energy-producing mitochondria (taken from egg precursor cells) is combined with sperm and added to a woman’s ova in order to improve the health of a woman’s existing eggs. To read more about the family’s fertility journey, please follow the link to: the original TIME Magazine article. This past October, Dr. Dixon attended the annual conference of the American Society for Reproductive Medicine, where she was invited to join the executive committee of the first, LGBTQ “Special Interest Groupâ€. Its goal will be to focus on advocacy and accessibility to fertility care for all members of every community. Dr. Dixon has also endeavoured to provide educational programs geared toward the LGBTQ Community. In early 2015, she sponsored a training video produced by the “LGBTQ Parenting Network†entitled “Scenes from a Fertility Clinic – LGBTQ People & Assisted Human Reproductionâ€. She also is a regular sponsor of Pride week family activities, both locally and internationally. Dr. Dixon views her role as a fertility specialist as a privilege, and prides herself on offering individualized patient care. It is her passion for her field that drives her determination to continually improve the quality and accessibility of fertility services available to Canadians-right here in our own community!
Research Interest
Obstetrics and Gynecology
Biography
n his role of Chair of Obstetrics and Gyncology, and of Gynecologist-in-Chief at the MUHC, Dr. Tan has brought generational change to the challenges of human infertility, assisting countless families and positioning the University at the forefront in this field. In 1996, he founded the McGill Reproductive Centre and steadily expanded its capabilities through exceptional research and commitment. Dr. Tan and his team of specialists have achieved in-vitro fertilization (IVF) pregnancy rates that are among the highest in the world. An internationally regarded infertility expert, he also is viewed as a pioneer in the simplification of the IVF process. Dr. Tan led the McGill team that produced the world’s first air transport IVF and intra-cytoplasmic sperm injection pregnancies. He and his team were the first in Canada to use in-vitro maturation of human oocytes for the treatment of infertility, as well as in-vitro maturation and vitrification of oocytes to preserve fertility in young women undergoing cancer treatment. Under Dr. Tan’s innovative leadership, his team created the McGill Cryoleaf, which protects the egg as it undergoes super-rapid cooling, increasing its survival rate to approximately 90 per cent. As a result of this groundbreaking work, the team was the first in the world to achieve a live birth from an egg that was matured through IVF, vitrified and then thawed. During his term as Chair, Dr. Tan was a strong advocate of scholarship and research within the Department. He was responsible for the creation of eight fellowship awards: the Brian Little Fellowship in Reproductive Medicine, the Robert Kinch Fellowship in Obstetrics and Gynecology, the Robert Usher Fellowship in Perinatology, the Frederick Naftolin Fellowship in Reproductive Medicine, the Charles W. McDougall Fellowship in Reproductive Medicine, two Women’s Health Fellowships in Reproductive Medicine and a fellowship in advanced gynecologic endoscopic surgery. To ensure that the Department remained at the forefront of medical education within Canada and around the world, Dr. Tan was also the driving force behind the creation of two endowed chairs: the Milton Leong Chair in Reproductive Medicine and the Richard Cruess Chair in Reproductive Biology. While Dr. Tan has stepped down as Chair of the Department, and as Obstetrician and Gynecologist-in-Chief at the MUHC, he remains with the McGill community to inspire the next generation in the field and continue on his exceptional path of discovery and care.
Research Interest
Obstetrics & Gynecology
Biography
Megan-Marie Stewart is a seasoned Businesswoman who resides in Seattle, Washington. Hailing from Boston, Massachusetts, her passion for all-things business and helping others began early on and has stayed with her ever since. Currently, Megan-Marie an Executive Office Administrator at The Boeing Company. Additionally, she is the proud Founder & Executive Director of PCOS Awareness Association, the second largest nonprofit organization dedicated to Polycystic Ovarian Syndrome worldwide. Megan-Marie’s mission is to revolutionize the way people approach education surrounding PCOS awareness. Most importantly, she is extremely dedicated to fighting for women with PCOS. Throughout the years, Megan-Marie has received a multitude of awards. Recently, she was the Winner of BECU People Helping People Award and a Winner of the 2015 Color of Teal’s Survivor Award. She also was nominated for the prestigious L’Oreal Women of Worth Award. As a passionate, selfless, and philanthropic individual, Megan-Marie is very committed to her community and consistently gives back to those in need. Needless to say, her work ethic and devotion to inspiring others is unwavering. When she isn’t focused on her multifaceted career and volunteer work, Megan-Marie enjoys taking classes on topics of interest, networking, and discovering new places. Megan-Marie Stewart holds a Bachelor of Business Administration with a focus in Project Management.
Research Interest
Polycystic Ovarian Syndrome